Under construction





  1. Achterbergh R, van der Helm JJ, van den Boom W, Heijman T, Stolte IG, van Rooijen MS, de Vries H. Is rectal douching and sharing douching equipment associated with anorectal chlamydia and gonorrhoea? A cross-sectional study among men who have sex with men. Sex Transm Infect. 2017 vol. 93 p. 431-437
  2. Achterbergh RCA, van der Helm JJ, van den Brink W, de Vries HJC. Design of a syndemic based intervention to facilitate care for men who have sex with men with high risk behaviour: the randomized controlled trial. BMC Infect Dis. 2017 Jun 6;17(1):398.
  3. Achterbergh RCA, Bruisten SM, V D Laar TJW, van der Weijden CP, Scholing M, Cornelissen M, de Vries HJC. An HIV-negative Same-sex Male Couple Both Infected With Hepatitis C Virus. Acta Derm Venereol. 2017 Nov 15;97(10):1255-1257
  4. Alberts CJ, van der Loeff MF, Hazeveld Y, de Melker HE, van der Wal MF, Nielen A, El Fakiri F, Prins M, Paulussen TG. A longitudinal study on determinants of HPV vaccination uptake in parents/guardians from different ethnic backgrounds in Amsterdam, the Netherlands. BMC Public Health. 2017 Feb 21;17(1):220.
  5. Alberts CJ, Michel A, Bruisten S, Snijder MB, Prins M, Waterboer T, Schim van der Loeff MF. High-risk human papillomavirus seroprevalence in men and women of six different ethnicities in Amsterdam, the Netherlands: The HELIUS study. Papillomavirus Res. 2017 Jun;3:57-65.
  6. Bartelsman M, Joore IK, van Bergen JE, Hogewoning AA, Zuure FR, van Veen MG; HIV Transmission Elimination AMsterdam (H-TEAM) initiative. HIV testing week 2015: lowering barriers for HIV testing among high-risk groups in Amsterdam. BMC Infect Dis. 2017 Aug 1;17(1):529.
  7. Bartelsman M, Vaughan K, van Rooijen MS, de Vries HJC, Xiridou M. Impact of point-of care management on the transmission of anogenital gonococcal infections among men who have sex with men in Amsterdam: a mathematical modelling and cost-effectiveness study. Sex Transm Infect. 2017 Sep 23. pii: sextrans-2017-053159.
  8. Bil JP, Prins M, Stolte IG, Dijkshoorn H, Heijman T, Snijder MB, Davidovich U, Zuure FR. Usage of purchased self-tests for HIV and sexually transmitted infections in Amsterdam, the Netherlands: results of population-based and serial cross-sectional studies amongthe general population and sexual risk groups. BMJ Open. 2017 Sep 21;7(9):e016609.
  9. Booiman T, Wit FW, Maurer I, De Francesco D, Sabin CA, Harskamp AM, Prins M, Garagnani P, Pirazzini C, Franceschi C, Fuchs D, Gisslén M, Winston A, Reiss P, Kootstra NA; Comorbidity in Relation to AIDS (COBRA) Collaboration. High Cellular Monocyte Activation in People Living With Human Immunodeficiency Virus on Combination Antiretroviral Therapy and Lifestyle-Matched Controls Is Associated With Greater Inflammation in Cerebrospinal Fluid. Open Forum Infect Dis. 2017 May 25;4(3):ofx108.
  10. Booiman T, Wit FW, Girigorie AF, Maurer I, De Francesco D, Sabin CA, Harskamp AM, Prins M, Franceschi C, Deeks SG, Winston A, Reiss P, Kootstra NA; Co-morBidity inRelation to Aids (COBRA) Collaboration. Terminal differentiation of T cells is strongly associated with CMV infection and increased in HIV-positive individuals on ART andlifestyle matched controls. PLoS One. 2017 Aug 14;12(8):e0183357.
  11. Borgdorff H, van der Veer C, van Houdt R, Alberts CJ, de Vries HJ, Bruisten SM, Snijder MB, Prins M, Geerlings SE, Schim van der Loeff MF, van de Wijgert JHHM. The association between ethnicity and vaginal microbiota composition in Amsterdam, the Netherlands. PLoS One. 2017 Jul 11;12(7):e0181135.
  12. Bouteloup V, Sabin C, Mocroft A, Gras L, Pantazis N, Le Moing V, d’Arminio Monforte A, Mary-Krause M, Roca B, Miro JM, Battegay M, Brockmeyer N, Berenguer J, Morlat P, Obel N, De Wit S, Fätkenheuer G, Zangerle R, Ghosn J, Pérez-Hoyos S, Campbell M, Prins M, Chêne G, Meyer L, Dorrucci M, Torti C, Thiébaut R; Standard Reference Distribution of CD4 Response to HAART Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord. Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients. HIV Med. 2017 Jan;18(1):33-44.
  13. Cole JH, Underwood J, Caan MW, De Francesco D, van Zoest RA, Leech R, Wit FW, Portegies P, Geurtsen GJ, Schmand BA, Schim van der Loeff MF, Franceschi C, Sabin CA, Majoie CB, Winston A, Reiss P, Sharp DJ; COBRA collaboration. Increased brain-predicted aging in treated HIV disease. Neurology. 2017 Apr 4;88(14):1349-1357.
  14. Coleman R, Prins M. Options for affordable pre-exposure prophylaxis (PrEP) in national HIV prevention programmes in Europe (editorial). Eurosurveillance 2017 Oct;22(47)
  15. de Gier B, Suryapranata FS, Croughs M, van Genderen PJ, Keuter M, Visser LG, van Vugt M, Sonder GJ. Increase in imported malaria in the Netherlands in asylum seekers and VFR travellers. Malar J. 2017 Feb 2;16(1):60.
  16. de Vries HJC, Baral S. Assessing the health and well-being of gay, bisexual and other men who have sex with men around the world. Sex Transm Infect. 2017 Aug;93(5):303-304.
  17. de Vrieze NHN, Versteeg B, Bruisten SM, van Rooijen MS, van der Helm JJ, de Vries HJC. Low Prevalence of Urethral Lymphogranuloma Venereum Infections Among Men Who Have Sex With Men: A Prospective Observational Study, Sexually Transmitted Infection Clinic in Amsterdam, the Netherlands. Sex Transm Dis. 2017 Sep;44(9):547-550.
  18. Demczuk W, Sidhu S, Unemo M, Whiley DM, Allen VG, Dillon JR, Cole M, Seah C, Trembizki E, Trees DL, Kersh EN, Abrams AJ, de Vries HJ, van Dam AP, Medina I, Bharat A, Mulvey MR, Van Domselaar G, Martin I. Neisseria gonorrhoeae Sequence Typing for Antimicrobial Resistance (NG-STAR): a novel antimicrobial resistance multilocus typing scheme for tracking the global dissemination of N. gonorrhoeae strains. J Clin Microbiol. 2017 May;55(5):1454-1468.
  19. Dijkstra M, de Bree GJ, Stolte IG, Davidovich U, Sanders EJ, Prins M, Schim van der Loeff MF. Development and validation of a risk score to assist screening for acute HIV-1 infection among men who have sex with men. BMC Infect Dis. 2017 Jun 14;17(1):425.
  20. Drückler S, van Rooijen MS, de Vries HJC. Chemsex among men who have sex with men: a sexualized drug use survey among clients of the sexually transmittted infection outpatient clinic and users of a gay dating app in Amsterdam, the Netherlands. SexTransm Dis 2017 Oct.
  21. Dukers NHTM, van Rooijen MS, Hogewoning A, van Liere GAFS, Steenbakkers M, Hoebe CJPA. Incidence of repeat testing and diagnoses of Chlamydia trachomatis and Neisseria gonorrhoea in swingers, homosexual and heterosexual men and women at two large Dutch STI clinics, 2006-2013. Sex Transm Infect. 2017; 93: p. 383–389
  22. Eltahla AA, Rodrigo C, Betz-Stablein B, Grebely J, Applegate T, Luciani F, Schinkel J, Dore GJ, Page K, Bruneau J, Morris MD, Cox AL, Kim AY, Shoukry NH, Lauer GM, Maher L, Hellard M, Prins M, Lloyd AR, Bull RA; InC3 Study Group. Analysis of resistance-associated substitutions in acute hepatitis C virus infection by deep sequencing across six genotypes and three continents. J Viral Hepat. 2017 Jan;24(1):37-42.
  23. European Union HCV Collaborators. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study. Lancet Gastroenterol Hepatol. 2017 May;2(5):325-336.
  24. Fakoya I, Álvarez-Del Arco D, Copas AJ, Teixeira B, Block K, Gennotte AF, Volny-Anne A, Bil JP, Touloumi G, Del Amo J, Burns FM. Factors Associated With Access to HIV Testing and Primary Care Among Migrants Living in Europe: Cross-Sectional Survey. JMIR Public Health Surveill. 2017 Nov 6;3(4):e84.
  25. Franse CB, Kayigamba FR, Bakker MI, Mugisha V, Bagiruwigize E, Mitchell KR, Asiimwe A, Schim van der Loeff MF. Linkage to HIV care before and after the introduction of provider-initiated testing and counselling in six Rwandan health facilities. AIDS Care. 2017 Mar;29(3):326-334.
  26. Freidl GS, Sonder GJ, Bovée LP, Friesema IH, van Rijckevorsel GG, Ruijs WL, van Schie F, Siedenburg EC, Yang JY, Vennema H. Hepatitis A outbreak among men who have sex with men (MSM) predominantly linked with the EuroPride, the Netherlands, July 2016 to February 2017. Euro Surveill. 2017 Feb 23;22(8). pii: 30468.
  27. Grijsen ML, de Vries HJC. Kerion. CMAJ. 2017 May 23;189(20):E725.
  28. Hananta IPY, van Dam AP, Bruisten SM, Schim van der Loeff MF, Soebono H, de Vries HJC. Value of light microscopy to diagnose urogenital gonorrhoea: a diagnostic test study in Indonesian clinic-based and outreach sexually transmitted infections services. BMJ Open. 2017 Aug 11;7(8):e016202.
  29. Hananta IPY, De Vries HJC, van Dam AP, van Rooijen MS, Soebono H, Schim van der Loeff MF. Persistence after treatment of pharyngeal gonococcal infections in patients of the STI clinic, Amsterdam, the Netherlands, 2012-2015: a retrospective cohort study. Sex Transm Infect. 2017 Aug 19. pii: sextrans-2017-053147.
  30. Heijman T, Zuure F, Stolte I, Davidovich U. Motives and barriers to safer sex and regular STI testing among MSM soon after HIV diagnosis. BMC Infectious Diseases BMC Infect Dis. 2017 Mar 7;17(1):194.
  31. Hoornenborg E, Achterbergh RCA, Schim Van Der Loeff MF, Davidovich U, Hogewoning A, Vries HJC, Schinkel J, Prins M, Laar TJWV, on behalf of the Amsterdam PrEP Project team in the HIV Transmission Elimination AMsterdam Initiative, MOSAIC study group. MSM starting pre-exposure prophylaxis (PrEP) are at risk of HCV infection. AIDS 2017 Jul 17;31(11):1603-1610.
  32. Hoornenborg E, Krakower DS, Prins M, Mayer KH. Preexposure prophylaxis for men who have sex with men and transgender persons in early adopting countries: a narrative review. AIDS. 2017 Aug 28.
  33. Jehee I, van der Veer C, Himschoot M, Hermans M, Bruisten S. Direct detection of Trichomonas vaginalis virus in Trichomonas vaginalis positive clinical samples from the Netherlands. J Virol Methods. 2017 Sep 13;250:1-5.
  34. Joosten R, Sonder G, Parkkali S, Brandwagt D, Fanoy E, Mughini-Gras L, Lodder W, Ruland E, Siedenburg E, Kliffen S, van Pelt W. Risk factors for gastroenteritis associated with canal swimming in two cities in the Netherlands during the summer of 2015: A prospective study. PLoS One. 2017 Apr 3;12(4):e0174732.
  35. Kooij KW, Vogt L, Wit FWNM, van der Valk M, van Zoest RA, Goorhuis A, Prins M, Post FA, Reiss P; AGEhIV Cohort Study. Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virus-Uninfected Controls. J InfectDis. 2017 Sep 15;216(6):622-631.
  36. Mangen MJ, Stibbe H, Urbanus A, Siedenburg EC, Waldhober Q, de Wit GA, van Steenbergen JE; National Working Group of hepatitis B behavioural risk-groups vaccination program. Targeted outreach hepatitis B vaccination program in high-risk adults: The fundamental challenge of the last mile. Vaccine. 2017 May 31;35(24):3215-3221. .
  37. Marra E, van Dam L, Kroone N, Craanen M, Zimet GD, Heijman T, Hogewoning AA, Sonder GJB, de Vries HJC, Alberts CJ, Paulussen TGWM, Schim van der Loeff MF. Determinants of Human Papillomavirus Vaccination Intention Among Female Sex Workers in Amsterdam, the Netherlands. Sex Transm Dis. 2017 44(12):756–762.
  38. Morris MD, Shiboski S, Bruneau J, Hahn JA, Hellard M, Prins M, Cox AL, Dore G, Grebely J, Kim AY,Lauer GM, Lloyd A,Rice T,Shoukry N, Maher L, Page K; for the International Collaboration of Incident HIV and HCV in Injecting Cohorts (InC3). Geographic Differences in Temporal Incidence Trends of Hepatitis C Virus Infection Among People Who Inject Drugs: The InC3 Collaboration. Clin Infect Dis. 2017 Apr 1;64(7):860-869.
  39. Newsum AM, Ho CK, Lieveld FI, van de Laar TJ, Koekkoek SM, Rebers SP, van der Meer JT, Wensing AM, Boland GJ, Arends JE, van Erpecum KJ, Prins M, Molenkamp R, Schinkel J. The hepatitis C virus nonstructural protein 3 Q80K polymorphism is frequently detected and transmitted among HIV-infected MSM in the Netherlands. AIDS. 2017 Jan 2;31(1):105-112.
  40. Newsum AM, Stolte IG, van der Meer JT, Schinkel J, van der Valk M, Vanhommerig JW, Buvé A, Danta M, Hogewoning A, Prins M; MOSAIC (MSM). Development and validation of the HCV-MOSAIC risk score to assist testing for acute hepatitis C virus (HCV) infection in HIV-infected men who have sex with men (MSM). Euro Surveill. 2017 May 25;22(21). pii: 30540.
  41. Newsum AM, Schinkel J, van de Laar TJW, van der Meer JTM, Prins M. Spontaneous clearance of Hepatitis C virus infection among Human ImmunodeficiencyVirus-Infected men who sex with men (brief report). Open Forum Infectious Diseases, Volume 4, Issue 2, 1 April 2017, ofx090.
  42. Prins M, Bruneau J. Estimates are not enough: scaling-up interventions to improve the health of people who inject drugs. Lancet Glob Health 2017 Dec;5(12):e1162-e1163.
  43. Reyniers T, Hoornenborg E, Vuylsteke B, Wouters K, Laga M. Pre-exposure prophylaxis (PrEP) for men who have sex with men in Europe: review of evidence for a much needed prevention tool. Sex Transm Infect. 2017 Aug;93(5):363-367.
  44. Rodrigo C, Eltahla AA, Bull RA, Luciani F, Grebely J, Dore GJ, Applegate T, Page K, Bruneau J, Morris MD, Cox AL, Osburn W, Kim AY, Shoukry NH, Lauer GM, Maher L, Schinkel J, Prins M, Hellard M, Lloyd AR; InC3 Collaborative. Phylogenetic analysis of full-length, early infection, hepatitis C virus genomes among people with intravenous drug use: the InC3 Study. J Viral Hepat. 2017 Jan;24(1):43-52.
  45. Rodrigo C, Walker MR, Leung P, Eltahla AA, Grebely J, Dore GJ, Applegate T, Page K, Dwivedi S, Bruneau J, Morris MD, Cox AL, Osburn W, Kim AY, Schinkel J, Shoukry NH, Lauer GM, Maher L, Hellard M, Prins M, Luciani F, Lloyd AR, Bull RA; InC3 Study Group. Limited naturally occurring escape in broadly neutralizing antibody epitopes in hepatitis C glycoprotein E2 and constrained sequence usage in acute infection. Infect Infect Genet Evol. 2017 Jan 5;49:88-96.
  46. van Santen DK, van der Helm JJ, Del Amo J, Meyer L, D’Arminio Monforte A, Price M, Béguelin CA, Zangerle R, Sannes M, Porter K, Geskus RB, Prins M; CASCADE Collaboration in EuroCoord. Lack of decline in hepatitis C virus incidence among HIV-positive men who have sex with men during 1990-2014. J Hepatol. olume 67, Issue 2, August 2017, Pages 255-262.
  47. van Santen DK, van der Helm JJ, Lindenburg K, Schim van der Loeff M, Prins M. HIV and hepatitis C treatment uptake among people who use drugs participating in the Amsterdam Cohort Studies, 1985-2015. Int J Drug Policy. Volume 47, September 2017, Pages 95-10
  48. Seth-Smith HM, Galán JC, Goldenberger D, Lewis DA, Peuchant O, Bébéar C, de Barbeyrac B, Bénard A, Carter I, Kok J, Bruisten SM, Versteeg B, Morré SA, Thomson NR, Egli A, de Vries HJ. Concern regarding the alleged spread of hypervirulent lymphogranuloma venereum Chlamydia trachomatis strain in Europe. Euro Surveill. 2017 Apr 13;22(15). pii: 30511.
  49. Siegenbeek van Heukelom ML, Marra E, de Vries HJC, Schim van der Loeff MF, Prins JM. Risk factors for anal high-grade squamous intraepithelial lesions in HIV-positive MSM: is targeted screening possible? AIDS. 2017 Oct 23;31(16):2295-2301.
  50. Smelov V, Vrbanac A, van Ess EF, Noz MP, Wan R, Eklund C, Morgan T, Shrier LA, Sanders B, Dillner J, de Vries HJC, Morre SA, Dean D. Chlamydia trachomatis Strain Types Have Diversified Regionally and Globally with Evidence for Recombination across Geographic Divides. Front Microbiol. 2017 Nov 13;8:2195
  51. Strouhal M, Mikalová L, Havlíčková P, Tenti P, Čejková D, Rychlík I, Bruisten S, Šmajs D. Complete genome sequences of two strains of Treponema pallidum subsp. pertenue from Ghana, Africa: Identical genome sequences in samples isolated more than 7 years apart. PLoS Negl Trop Dis. 2017 Sep 8;11(9):e0005894.
  52. Su T, Mutsaerts HJ, Caan MW, Wit FW, Schouten J, Geurtsen GJ, Sharp DJ, Prins M, Richard E, Portegies P, Reiss P, Majoie CB; AGEhIV Cohort Study. Cerebral blood flow and cognitive function in HIV-infected men with sustained suppressed viremia on combination antiretroviral therapy. AIDS. 2017 Mar 27;31(6):847-856.
  53. Sudenga SL, Torres BN, Botha MH, Zeier M, Abrahamsen ME, Glashoff RH, Engelbrecht S, Schim Van der Loeff MF, Van der Laan LE, Kipping S, Taylor D, Giuliano AR. HPV serostatus pre- and post-vaccination in a randomized phase ii preparedness trial among young western cape, South African women: the evri trial.  Papillomavirus Res. 2017 Jun;3:50-56.
  54. Unemo M, Bradshaw CS, Hocking JS, de Vries HJC, Francis SC, Mabey D, Marrazzo JM, Sonder GJB, Schwebke JR, Hoornenborg E, Peeling RW, Philip SS, Low N, Fairley CK. Sexually transmitted infections: challenges ahead. Lancet Infect Dis. Volume 17, Issue 8, August 2017, Pages e235-e279
  55. Vanhommerig JW, Bezemer D, Molenkamp R, Van Sighem AI, Smit C, Arends JE, Lauw FN, Brinkman K, Rijnders BJ, Newsum AM, Bruisten SM, Prins M, Van Der Meer JT, Van De Laar TJ, Schinkel J; MOSAIC study and the ATHENA national observational cohort. Limited overlap between phylogenetic HIV and HCV clusters illustrates the dynamic sexual network structure of Dutch HIV-infected MSM. AIDS. AIDS. 31(15):2147–2158, SEP 2017
  56. Veer C van der, Bruisten SM, van der Helm JJ, de Vries HJ, van Houdt R. The Cervicovaginal Microbiota in Women Notified for Chlamydia trachomatis Infection: A Case-Control Study at the Sexually Transmitted Infection Outpatient Clinic in Amsterdam, The Netherlands. Clin Infect Dis. 2017 Jan 1;64(1):24-31.
  57. Versteeg B, Bruisten SM, Heijman T, Vermeulen W, van Rooijen MS, van Dam AP, Schim van der Loeff MF, de Vries HJC, Scholing M. Monitoring therapy success of urogenital Chlamydia trachomatis infections in women: A prospective observational cohort study. PLoS One. 2017 Sep 21;12(9):e0185295.
  58. Visser M, Heijne JCM, Hogewoning AA, van Aar F. Frequency and determinants of consistent STI/HIV testing among men who have sex with men testing at STI outpatient clinics in the Netherlands: a longitudinal study. Sex Transm Infect. 2017 Sep;93(6):396.
  59. Wagemakers A, Jahfari S, de Wever B, Spanjaard L, Starink MV, de Vries HJ, Sprong H, Hovius JW. Borrelia miyamotoi in vectors and hosts in The Netherlands. Ticks Tick Borne Dis. 2017 Mar;8(3):370-374.
  60. Wind CM, Schim van der Loeff MF, van Dam AP, de Vries HJ, van der Helm JJ. Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015. Euro Surveill. 2017 Jan 5;22(1). pii: 30431.
  61. Wind CM, de Vries E, Schim van der Loeff MF, van Rooijen MS, van Dam AP, Demczuk WH, Martin I, de Vries HJ. Decreased azithromycin susceptibility of Neisseria gonorrhoeae isolates in patients recently treated with azithromycin. Clin Infect Dis. 2017 Mar 24. [Epub ahead of print]
  62. Wind CM, Bruisten SM, Schim van der Loeff MF, Dierdorp M, de Vries HJC, van Dam AP. A Case-Control Study of Molecular Epidemiology in Relation to Azithromycin Resistance in Neisseria gonorrhoeae Isolates Collected in Amsterdam, the Netherlands, between 2008 and 2015. Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e02374-16.
  63. Wittkop L, Arsandaux J, Trevino A, Schim van der Loeff M, Anderson J, van Sighem A, Böni J, Brun-Vezinet F, Soriano V, Boufassa F, Brockmeyer N, Calmy A, Dabis F, Jarrin I, Dorrucci M, Duque V, Gätkenheuer G, Zangerle R, Ferrer E, Porter K, Judd A, Sipsas NV, Lambotte O, Shepherd L, Leport C, Morrison C, Mussini C, Obel N, Ruelle J, Schwarze-Zander C, Sonnerborg A, Teira R, Torti C, Valados E, Colin C, Friis-Moller N, Costagliola D, Thiebaut R, Chene G, and Matheron S, on behalf of the COHE in EuroCoord and ACHIeV2e Study Group. CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: a multinational, multicohort European study. J Antimicrob Chemother ;Volume 72, Issue 10, 1 October 2017, Pages 2869–2878
  64. Woestenberg PJ, King AJ, van der Sande MA, Donken R, Leussink S, van der Klis FR, Hoebe CJ, Bogaards JA, van Benthem BH, Medical Microbiological Laboratories; Public Health Services. No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors. J Infect 2017 Apr;74(4):393-400.
  65. van Zoest RA, van der Valk M, Wit FW, Vaartjes I, Kooij KW, Hovius JW, Prins M, Reiss P; AGEhIV Cohort Study Group. Suboptimal primary and secondary cardiovascular disease prevention in HIV-positive individuals on antiretroviral therapy. Eur J Prev Cardiol. 2017 Aug;24(12):1297-1307.